Biosenta Inc.
ZRO
CNSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 64.81% | 65.11% | -1,449.37% | -1,060.69% | -422.54% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -72.59% | -76.76% | 420.58% | 396.25% | 2,829.22% |
| Change in Net Operating Assets | -59.21% | -65.48% | -24.82% | -5.74% | 8.87% |
| Cash from Operations | 15.79% | -40.29% | -52.58% | -40.95% | -79.65% |
| Capital Expenditure | -59.48% | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -59.48% | -- | -- | -- | -- |
| Total Debt Issued | -34.13% | -100.00% | -77.19% | -22.52% | -16.22% |
| Total Debt Repaid | -- | -- | -60,100.00% | -- | -- |
| Issuance of Common Stock | 79.27% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 137.76% | -- | -- | -- | -- |
| Cash from Financing | -38.18% | 42.12% | 61.41% | 79.30% | 116.58% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -182.14% | 106.96% | 33.59% | 105.68% | 2,934.38% |